This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: ETH Zurich. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Samuel Nando Kilcher: Inventor in Bacteriophage-Based Infection Treatment.
Introduction
Samuel Nando Kilcher is an inventor associated with ETH Zurich in Zurich, Switzerland. His work includes an invention in the field of medicine focused on bacterial infections and their treatment.
Latest Patents
Kilcher is named on one patent, titled “Bacteriophages Producing Heterologous Bacteriocins.” The invention concerns bacteriophages that produce heterologous bacteriocins and explores their potential application in treating bacterial infections. The patent record lists 1 patent for him.
Career Highlights
Kilcher’s listed patent connects his inventive work with research at ETH Zurich and the development of approaches to bacterial infection treatment.
Collaborations
His listed collaborators include Martin Johannes Loessner and Matthew Stephen Dunne.
Conclusion
Samuel Nando Kilcher’s patent on bacteriophages producing heterologous bacteriocins reflects an effort to advance research into potential treatments for bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile